LL-100 panel

The LL-100 panel is a group of 100 human leukemia and lymphoma cell line,[1] can be used in model of biomedical research.[2]

Purpose

LL-100 panel cell lines cover the full spectrum of human leukemia and lymphoma including T-cell, B-cell and myeloid malignancies.[1]

List of LL-100 Cell Lines

Pre-B-ALL
Cell lineRefCellosaurus
697[3]CVCL_0079
KOPN-8[4]CVCL_1866
NALM-6[5]CVCL_0092
REH[6]CVCL_1650
SEM[7]CVCL_0095

B-NHL: Burkitt/B-ALL
Cell lineRefCellosaurus
BJAB[8]CVCL_5711
Daudi cell[9]CVCL_0008
Raji[10]CVCL_0511
RAMOS[11]CVCL_0597
VAL[12]CVCL_1819

B-NHL: CLL/PLL
Cell lineRefCellosaurus
HG-3[13]CVCL_Y547
JVM-3[14]CVCL_1320
JVM-13[15]CVCL_1318
MEC-1[16]CVCL_1870
PGA-1[17]CVCL_Y545

B-NHL: DLBCL ABC
Cell lineRefCellosaurus
NU-DHL-1[18]CVCL_1876
OCI-Ly3[19]CVCL_8800
Ri-1[20]CVCL_1885
U-2932[21]CVCL_1896
U-2946[22]CVCL_X503

B-NHL: DLBCL GC
Cell lineRefCellosaurus
DoHH2[23]CVCL_1179
OCI-Ly7[19]CVCL_1881
OCI-Ly19[24]CVCL_1878
SU-DHL-4[25]CVCL_0539
SU-DHL-6[25]CVCL_2206
WSU-DLCL2[26]CVCL_1902

B-NHL: HCL
Cell lineRefCellosaurus
BONNA-12[27]CVCL_1090
Hair-M[28]CVCL_B401
HC-1[29]CVCL_1243

B-NHL: MCL
Cell lineRefCellosaurus
Granta-519[30]CVCL_1818
JeKo-1[31]CVCL_1865
JVM-2[14]CVCL_1319
Mino[32]CVCL_1872
REC-1[33]CVCL_1884

B-NHL: PEL
Cell lineRefCellosaurus
BC-3[34]CVCL_1080
BCBL-1[35]CVCL_0165
CRO-AP2[36]CVCL_1147
CRO-AP5[37]CVCL_1148

B-NHL: PMBL
Cell lineRefCellosaurus
U-2940[38]CVCL_1897

Multiple Myeloma/PCL
Cell lineRefCellosaurus
KMS-12-BM[39]CVCL_1334
L-363[40]CVCL_1357
LP-1[41]CVCL_0012
OPM-2[42]CVCL_1625
RPMI-8226[43]CVCL_0014
U-266[44]CVCL_0566

Hodgkin Lymphoma
Cell lineRefCellosaurus
HDLM-2[45]CVCL_0009
KM-H2[46]CVCL_1330
L-428[45]CVCL_1361
L-1236[47]CVCL_2096
SUP-HD1[48]CVCL_2208

T-ALL/T-LL
Cell lineRefCellosaurus
CCRF-CEM[49]CVCL_0207
DND-41[50]CVCL_2022
HPB-ALL[51]CVCL_1820
Jurkat[52]CVCL_0065
MOLT-4[53]CVCL_0013
RPMI-8402[54]CVCL_1667

Mature T-Malignancy
Cell lineRefCellosaurus
DERL-7[55]CVCL_2017
HH[56]CVCL_1280
MOTN-1[57]CVCL_2127

NK Malignancy
Cell lineRefCellosaurus
KHYG-1[58]CVCL_2976
NK-92[59]CVCL_2142
YT[60]CVCL_1797

ALCL
Cell lineRefCellosaurus
DELCVCL_
SR-786CVCL_
SU-DHL-1[61]CVCL_0538
SUP-M2CVCL_

AML myelocytic
Cell lineRefCellosaurus
EoL-1CVCL_
HL-60CVCL_
Kasumi-1CVCL_
KG-1CVCL_
NB4CVCL_
OCI-AML3CVCL_
SKNO-1CVCL_

AML monocytic
Cell lineRefCellosaurus
ME-1CVCL_
MOLM-13CVCL_
Mono-Mac-6CVCL_
MUTZ-3CVCL_
THP-1CVCL_
U-937CVCL_

AML erythroid
Cell lineRefCellosaurus
F-36PCVCL_
HELCVCL_
OCI-M2CVCL_
TF-1CVCL_

AML megakaryocytic
Cell lineRefCellosaurus
CMKCVCL_
ELF-153CVCL_
M-07eCVCL_
MEGALCVCL_
MKPL-1CVCL_
UT-7CVCL_

CML myeloid BC
Cell lineRefCellosaurus
EM-2CVCL_
K-562[62][63]CVCL_0004
KCL-22CVCL_
Ku812CVCL_
LAMA-84CVCL_
MOLM-20CVCL_

CML lymphoid BC
Cell lineRefCellosaurus
BV-173[64]CVCL_0181
CML-T1[65]CVCL_1126
NALM-1[66]CVCL_0091
TK-6[67]CVCL_X907

MPN
Cell lineRefCellosaurus
SET-2[68]CVCL_2187

See also

References
  1. Quentmeier, H; Pommerenke, C; Dirks, WG; Eberth, S; Koeppel, M; MacLeod, RAF; Nagel, S; Steube, K; Uphoff, CC; Drexler, HG (3 June 2019). "The LL-100 panel: 100 cell lines for blood cancer studies". Scientific Reports. 9 (1): 8218. Bibcode:2019NatSR...9.8218Q. doi:10.1038/s41598-019-44491-x. PMC 6547646. PMID 31160637.
  2. Drexler, HG; Quentmeier, H (13 August 2020). "The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research". International Journal of Molecular Sciences. 21 (16): 5800. doi:10.3390/ijms21165800. PMC 7461097. PMID 32823535.
  3. Findley HW, Jr; Cooper, MD; Kim, TH; Alvarado, C; Ragab, AH (December 1982). "Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes". Blood. 60 (6): 1305–9. doi:10.1182/blood.V60.6.1305.1305. PMID 6982733.
  4. Uphoff, CC; MacLeod, RA; Denkmann, SA; Golub, TR; Borkhardt, A; Janssen, JW; Drexler, HG (March 1997). "Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines". Leukemia. 11 (3): 441–7. doi:10.1038/sj.leu.2400571. PMID 9067587. S2CID 37823510.
  5. Hurwitz, R; Hozier, J; LeBien, T; Minowada, J; Gajl-Peczalska, K; Kubonishi, I; Kersey, J (February 1979). "Characterization of a leukemic cell line of the pre-B phenotype". International Journal of Cancer. 23 (2): 174–80. doi:10.1002/ijc.2910230206. PMID 83966. S2CID 29853203.
  6. Rosenfeld, C; Goutner, A; Venuat, AM; Choquet, C; Pico, JL; Dore, JF; Liabeuf, A; Durandy, A; Desgrange, C; De The, G (April 1977). "An effect human leukaemic cell line: Reh". European Journal of Cancer. 13 (4–5): 377–9. doi:10.1016/0014-2964(77)90085-8. PMID 194778.
  7. Greil, J; Gramatzki, M; Burger, R; Marschalek, R; Peltner, M; Trautmann, U; Hansen-Hagge, TE; Bartram, CR; Fey, GH; Stehr, K (February 1994). "The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7". British Journal of Haematology. 86 (2): 275–83. doi:10.1111/j.1365-2141.1994.tb04726.x. PMID 8199015. S2CID 44321104.
  8. Menezes, J; Leibold, W; Klein, G; Clements, G (July 1975). "Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma". Biomédicine. 22 (4): 276–84. PMID 179629.
  9. Nadkarni, JS; Nadkarni, JJ; Clifford, P; Manolov, G; Fenyö, EM; Klein, E (January 1969). "Characteristics of new cell lines derived from Burkitt lymphomas". Cancer. 23 (1): 64–79. doi:10.1002/1097-0142(196901)23:1<64::aid-cncr2820230107>3.0.co;2-m. PMID 4178827.
  10. PULVERTAFT, JV (1 February 1964). "Cytology of Burkitt's Tumour (African Lymphoma)". Lancet. 1 (7327): 238–40. doi:10.1016/s0140-6736(64)92345-1. PMID 14086209.
  11. Klein, G; Giovanella, B; Westman, A; Stehlin, JS; Mumford, D (1975). "An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection". Intervirology. 5 (6): 319–34. doi:10.1159/000149930. PMID 181343.
  12. Kerckaert, JP; Deweindt, C; Tilly, H; Quief, S; Lecocq, G; Bastard, C (September 1993). "LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas". Nature Genetics. 5 (1): 66–70. doi:10.1038/ng0993-66. PMID 8220427. S2CID 12575122.
  13. Rosén, A; Bergh, AC; Gogok, P; Evaldsson, C; Myhrinder, AL; Hellqvist, E; Rasul, A; Björkholm, M; Jansson, M; Mansouri, L; Liu, A; Teh, BT; Rosenquist, R; Klein, E (1 January 2012). "Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection". Oncoimmunology. 1 (1): 18–27. doi:10.4161/onci.1.1.18400. PMC 3376971. PMID 22720208.
  14. Melo, JV; Brito-Babapulle, V; Foroni, L; Robinson, DS; Luzzatto, L; Catovsky, D (15 October 1986). "Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement". International Journal of Cancer. 38 (4): 531–8. doi:10.1002/ijc.2910380413. PMID 3093393. S2CID 10813284.
  15. Melo, JV; Foroni, L; Brito-Babapulle, V; Luzzatto, L; Catovsky, D (July 1988). "The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement". Clinical and Experimental Immunology. 73 (1): 23–8. PMC 1541467. PMID 3262465.
  16. Stacchini, A; Aragno, M; Vallario, A; Alfarano, A; Circosta, P; Gottardi, D; Faldella, A; Rege-Cambrin, G; Thunberg, U; Nilsson, K; Caligaris-Cappio, F (February 1999). "MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation". Leukemia Research. 23 (2): 127–36. doi:10.1016/s0145-2126(98)00154-4. PMID 10071128.
  17. Lewin, N; Aman, P; Mellstedt, H; Zech, L; Klein, G (15 June 1988). "Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines". International Journal of Cancer. 41 (6): 892–5. doi:10.1002/ijc.2910410621. PMID 2836321. S2CID 38575113.
  18. Epstein, AL; Variakojis, D; Berger, C; Hecht, BK (15 May 1985). "Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations". International Journal of Cancer. 35 (5): 619–27. doi:10.1002/ijc.2910350509. PMID 2581902. S2CID 38530935.
  19. Tweeddale, ME; Lim, B; Jamal, N; Robinson, J; Zalcberg, J; Lockwood, G; Minden, MD; Messner, HA (May 1987). "The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor". Blood. 69 (5): 1307–14. doi:10.1182/blood.V69.5.1307.1307. PMID 3567358.
  20. Th'ng, KH; Garewal, G; Kearney, L; Rassool, F; Melo, JV; White, H; Catovsky, D; Foroni, L; Luzzatto, L; Goldman, JM (15 January 1987). "Establishment and characterization of three new malignant lymphoid cell lines". International Journal of Cancer. 39 (1): 89–93. doi:10.1002/ijc.2910390116. PMID 3098690. S2CID 23849509.
  21. Amini, RM; Berglund, M; Rosenquist, R; Von Heideman, A; Lagercrantz, S; Thunberg, U; Bergh, J; Sundström, C; Glimelius, B; Enblad, G (November 2002). "A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma". Leukemia & Lymphoma. 43 (11): 2179–89. doi:10.1080/1042819021000032917. PMID 12533045. S2CID 23476994.
  22. Fridberg, M; Servin, A; Anagnostaki, L; Linderoth, J; Berglund, M; Söderberg, O; Enblad, G; Rosén, A; Mustelin, T; Jerkeman, M; Persson, JL; Wingren, AG (November 2007). "Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN". Leukemia & Lymphoma. 48 (11): 2221–32. doi:10.1080/10428190701636443. PMID 17926183. S2CID 17523509.
  23. Kluin-Nelemans, HC; Limpens, J; Meerabux, J; Beverstock, GC; Jansen, JH; de Jong, D; Kluin, PM (March 1991). "A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)". Leukemia. 5 (3): 221–4. PMID 1849602.
  24. Chang, H; Blondal, JA; Benchimol, S; Minden, MD; Messner, HA (September 1995). "p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines". Leukemia & Lymphoma. 19 (1–2): 165–71. doi:10.3109/10428199509059672. PMID 8574164.
  25. Epstein, AL; Herman, MM; Kim, H; Dorfman, RF; Kaplan, HS (May 1976). "Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse". Cancer. 37 (5): 2158–76. doi:10.1002/1097-0142(197605)37:5<2158::aid-cncr2820370503>3.0.co;2-f. PMID 177185.
  26. Al-Katib, AM; Smith, MR; Kamanda, WS; Pettit, GR; Hamdan, M; Mohamed, AN; Chelladurai, B; Mohammad, RM (May 1998). "Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts". Clinical Cancer Research. 4 (5): 1305–14. PMID 9607591.
  27. Wientjens, GJ; Jansen, JH; Wessels, HW; Kibbelaar, RE; Beverstock, GC; Brederoo, P; Kluin-Nelemans, HC (1991). "Characterization of a New Human B Cell Line (Bonna-12) with Trisomy 9 and Trisomy 12 Chromosomal Abnormality". Leukemia & Lymphoma. 5 (5–6): 415–22. doi:10.3109/10428199109067637. PMID 27463354.
  28. Matsuo, Y; Sagawa, K; Yokoyama, M; Koga, T; Yamaguchi, T; Morita, M; Minowada, J (November 1983). "[Establishment and characterization of hairy cell leukemia cell line (Hair-M)]". Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society. 46 (6): 1222–32. PMID 6608852.
  29. Schiller, JH; Bittner, G; Meisner, LF; Oberley, TD; Norback, D; Schwabe, M; Faltynek, CR; Raab-Traub, N (May 1991). "Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient". Leukemia. 5 (5): 399–407. PMID 1851909.
  30. Lukas, J; Jadayel, D; Bartkova, J; Nacheva, E; Dyer, MJ; Strauss, M; Bartek, J (August 1994). "BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation". Oncogene. 9 (8): 2159–67. PMID 8036001.
  31. Jeon, HJ; Kim, CW; Yoshino, T; Akagi, T (September 1998). "Establishment and characterization of a mantle cell lymphoma cell line". British Journal of Haematology. 102 (5): 1323–6. doi:10.1046/j.1365-2141.1998.00911.x. PMID 9753063. S2CID 29818033.
  32. Lai, R; McDonnell, TJ; O'Connor, SL; Medeiros, LJ; Oudat, R; Keating, M; Morgan, MB; Curiel, TJ; Ford, RJ (September 2002). "Establishment and characterization of a new mantle cell lymphoma cell line, Mino". Leukemia Research. 26 (9): 849–55. doi:10.1016/s0145-2126(02)00013-9. PMID 12127561.
  33. Szepetowski, P; Simon, MP; Grosgeorge, J; Huebner, K; Bastard, C; Evans, GA; Tsujimoto, Y; Birnbaum, D; Theillet, C; Gaudray, P (April 1992). "Localization of 11q13 loci with respect to regional chromosomal breakpoints". Genomics. 12 (4): 738–44. doi:10.1016/0888-7543(92)90303-a. PMID 1572647.
  34. Arvanitakis, L; Mesri, EA; Nador, RG; Said, JW; Asch, AS; Knowles, DM; Cesarman, E (1 October 1996). "Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus". Blood. 88 (7): 2648–54. PMID 8839859.
  35. Renne, R; Zhong, W; Herndier, B; McGrath, M; Abbey, N; Kedes, D; Ganem, D (March 1996). "Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture". Nature medicine. 2 (3): 342–6. doi:10.1038/nm0396-342. PMID 8612236.
  36. Carbone, A; Cilia, AM; Gloghini, A; Canzonieri, V; Pastore, C; Todesco, M; Cozzi, M; Perin, T; Volpe, R; Pinto, A; Gaidano, G (14 November 1997). "Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions". International journal of cancer. 73 (4): 562–9. doi:10.1002/(sici)1097-0215(19971114)73:4<562::aid-ijc18>3.0.co;2-b. PMID 9389573.
  37. Carbone, A; Cilia, AM; Gloghini, A; Capello, D; Todesco, M; Quattrone, S; Volpe, R; Gaidano, G (September 1998). "Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8". British journal of haematology. 102 (4): 1081–9. doi:10.1046/j.1365-2141.1998.00877.x. PMID 9734661.
  38. Sambade, C; Berglund, M; Lagercrantz, S; Sällström, J; Reis, RM; Enblad, G; Glimelius, B; Sundström, C (1 February 2006). "U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma". International Journal of Cancer. 118 (3): 555–63. doi:10.1002/ijc.21417. PMID 16106419. S2CID 12837372.
  39. Ohtsuki, T; Yawata, Y; Wada, H; Sugihara, T; Mori, M; Namba, M (October 1989). "Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)". British journal of haematology. 73 (2): 199–204. doi:10.1111/j.1365-2141.1989.tb00252.x. PMID 2479409.
  40. Diehl, V; Schaadt, M; Kirchner, H; Hellriegel, KP; Gudat, F; Fonatsch, C; Laskewitz, E; Guggenheim, R (20 June 1978). "Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study". Blut. 36 (6): 331–8. doi:10.1007/BF01000590. PMID 207377.
  41. Pegoraro, L; Malavasi, F; Bellone, G; Massaia, M; Boccadoro, M; Saglio, G; Guerrasio, A; Benetton, G; Lombardi, L; Coda, R (March 1989). "The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation". Blood. 73 (4): 1020–7. PMID 2784066.
  42. Katagiri, S; Yonezawa, T; Kuyama, J; Kanayama, Y; Nishida, K; Abe, T; Tamaki, T; Ohnishi, M; Tarui, S (15 August 1985). "Two distinct human myeloma cell lines originating from one patient with myeloma". International journal of cancer. 36 (2): 241–6. doi:10.1002/ijc.2910360217. PMID 3926660.
  43. Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D (August 1967). "Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 125 (4): 1246–50. doi:10.3181/00379727-125-32327. PMID 6042436.
  44. Nilsson, K; Bennich, H; Johansson, SG; Pontén, J (October 1970). "Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient". Clinical and experimental immunology. 7 (4): 477–89. PMID 4097745.
  45. Drexler, HG; Gaedicke, G; Lok, MS; Diehl, V; Minowada, J (1986). "Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles". Leukemia Research. 10 (5): 487–500. doi:10.1016/0145-2126(86)90084-6. PMID 3713248.
  46. Kamesaki, H; Fukuhara, S; Tatsumi, E; Uchino, H; Yamabe, H; Miwa, H; Shirakawa, S; Hatanaka, M; Honjo, T (July 1986). "Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease". Blood. 68 (1): 285–92. doi:10.1182/blood.V68.1.285.285. PMID 3013343.
  47. Wolf, J; Kapp, U; Bohlen, H; Kornacker, M; Schoch, C; Stahl, B; Mücke, S; von Kalle, C; Fonatsch, C; Schaefer, HE; Hansmann, ML; Diehl, V (15 April 1996). "Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells". Blood. 87 (8): 3418–28. doi:10.1182/blood.V87.8.3418.bloodjournal8783418. PMID 8605360.
  48. Naumovski, L; Utz, PJ; Bergstrom, SK; Morgan, R; Molina, A; Toole, JJ; Glader, BE; McFall, P; Weiss, LM; Warnke, R (December 1989). "SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma". Blood. 74 (8): 2733–42. doi:10.1182/blood.V74.8.2733.2733. PMID 2554995.
  49. FOLEY, GE; LAZARUS, H; FARBER, S; UZMAN, BG; BOONE, BA; MCCARTHY, RE (April 1965). "Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia". Cancer. 18 (4): 522–9. doi:10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j. PMID 14278051.
  50. Heyman, M; Grandér, D; Bröndum-Nielsen, K; Cederblad, B; Liu, Y; Xu, B; Einhorn, S (March 1994). "Interferon system defects in malignant T-cells". Leukemia. 8 (3): 425–34. PMID 8127147.
  51. Morikawa, S; Tatsumi, E; Baba, M; Harada, T; Yasuhira, K (15 February 1978). "Two E-rosette-forming lymphoid cell lines". International Journal of Cancer. 21 (2): 166–70. doi:10.1002/ijc.2910210207. PMID 203546. S2CID 9032666.
  52. Abraham, RT; Weiss, A (April 2004). "Jurkat T cells and development of the T-cell receptor signalling paradigm". Nature Reviews. Immunology. 4 (4): 301–8. doi:10.1038/nri1330. PMID 15057788. S2CID 13253575.
  53. Minowada, J; Onuma, T; Moore, GE (September 1972). "Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes". Journal of the National Cancer Institute. 49 (3): 891–5. PMID 4567231.
  54. Huang, CC; Hou, Y; Woods, LK; Moore, GE; Minowada, J (September 1974). "Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia". Journal of the National Cancer Institute. 53 (3): 655–60. doi:10.1093/jnci/53.3.655. PMID 4547172.
  55. Di Noto, R; Pane, F; Camera, A; Luciano, L; Barone, M; Lo Pardo, C; Boccuni, P; Intrieri, M; Izzo, B; Villa, MR; Macrí, M; Rotoli, B; Sacchetti, L; Salvatore, F; Del Vecchio, L (October 2001). "Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma". Leukemia. 15 (10): 1641–9. doi:10.1038/sj.leu.2402239. PMID 11587224.
  56. Starkebaum, G; Loughran TP, Jr; Waters, CA; Ruscetti, FW (9 September 1991). "Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor". International journal of cancer. 49 (2): 246–53. doi:10.1002/ijc.2910490218. PMID 1879969.
  57. Matsuo, Y; Drexler, HG; Takeuchi, M; Tanaka, M; Orita, K (September 2002). "Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens". Leukemia research. 26 (9): 873–9. doi:10.1016/s0145-2126(02)00023-1. PMID 12127564.
  58. Yagita, M; Huang, CL; Umehara, H; Matsuo, Y; Tabata, R; Miyake, M; Konaka, Y; Takatsuki, K (May 2000). "A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation". Leukemia. 14 (5): 922–30. doi:10.1038/sj.leu.2401769. PMID 10803526.
  59. Gong, J., Maki, G., and Klingemann, H-G. (1994). “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells”. Leukemia; 8: 652-58.
  60. Yodoi, J; Teshigawara, K; Nikaido, T; Fukui, K; Noma, T; Honjo, T; Takigawa, M; Sasaki, M; Minato, N; Tsudo, M (March 1985). "TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)". Journal of immunology (Baltimore, Md. : 1950). 134 (3): 1623–30. PMID 2578514.
  61. Epstein, AL; Kaplan, HS (December 1974). "Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas". Cancer. 34 (6): 1851–72. doi:10.1002/1097-0142(197412)34:6<1851::aid-cncr2820340602>3.0.co;2-4. PMID 4140017.
  62. Lozzio CB, Lozzio BB (March 1975). "Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome". Blood. 45 (3): 321–334. PMID 163658.
  63. Drexler HG (2000). The Leukemia-Lymphoma Cell Line Factsbook. San Diego: Academic Press.
  64. Pegoraro, L; Matera, L; Ritz, J; Levis, A; Palumbo, A; Biagini, G (March 1983). "Establishment of a Ph1-positive human cell line (BV173)". Journal of the National Cancer Institute. 70 (3): 447–53. PMID 6572735.
  65. Kuriyama, K; Gale, RP; Tomonaga, M; Ikeda, S; Yao, E; Klisak, I; Whelan, K; Yakir, H; Ichimaru, M; Sparkes, RS (September 1989). "CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia". Blood. 74 (4): 1381–7. PMID 2788468.
  66. Minowada, J; Tsubota, T; Greaves, MF; Walters, TR (July 1977). "A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens". Journal of the National Cancer Institute. 59 (1): 83–7. doi:10.1093/jnci/59.1.83. PMID 301573.
  67. Watanabe, T; Kataoka, T; Mizuta, S; Kobayashi, M; Uchida, T; Imai, K; Wada, H; Kinoshita, T; Murate, T; Mizutani, S (November 1995). "Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein". Leukemia. 9 (11): 1926–34. PMID 7475285.
  68. Uozumi, K; Otsuka, M; Ohno, N; Moriyama, T; Suzuki, S; Shimotakahara, S; Matsumura, I; Hanada, S; Arima, T (January 2000). "Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles". Leukemia. 14 (1): 142–52. doi:10.1038/sj.leu.2401608. PMID 10637490. S2CID 3258153.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.